SCHEMBL14981982

SCHEMBL14981982

CCOC(=O)/C=C/C(=O)N(O)CCCN(C)Cc1ccc(CNC(=O)Nc2ccc(N(C)C)cc2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 6/20 0.42
LSS P48449 1/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
KMT2A Q03164 2/20 0.41
MEN1 O00255 1/20 0.41
NPC1 O15118 4/20 0.40
MAPT P10636 3/20 0.40
RAB9A P51151 3/20 0.40
ALDH1A1 P00352 1/20 0.40
F7 P08709 1/20 0.40
GAA P10253 1/20 0.39
EPHX2 P34913 1/20 0.38
CNR1 P21554 1/20 0.38
PPID Q08752 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
RORC P51449 1/20 0.37
HDAC3 O15379 1/20 0.37
HDAC4 P56524 1/20 0.37
HDAC1 Q13547 1/20 0.37
HDAC7 Q8WUI4 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14981983 0.88 KDM6B (0.46) NAMPTLSSKMT2AMEN1NPC1
SCHEMBL14981978 0.87 ALDH1A1 (0.43) NAMPTL3MBTL1KMT2AMEN1NPC1
SCHEMBL14985131 0.79 KDM4E (0.50) NAMPTL3MBTL1KMT2AMEN1NPC1
SCHEMBL14985108 0.77 KDM6B (0.58) NAMPTLSSKMT2AMEN1NPC1
SCHEMBL14981979 0.76 KDM4E (0.47) L3MBTL1KMT2AMEN1NPC1MAPT
SCHEMBL14985124 0.71 KDM4E (0.55) L3MBTL1KMT2AMEN1NPC1MAPT
SCHEMBL14981981 0.69 KDM4E (0.45) L3MBTL1KMT2AMEN1NPC1MAPT
SCHEMBL14985104 0.69 KDM4E (0.61) L3MBTL1KMT2AMEN1NPC1MAPT
SCHEMBL14985125 0.68 KDM4E (0.65) L3MBTL1KMT2AMEN1NPC1MAPT
SCHEMBL14981980 0.68 ALDH1A1 (0.40) NAMPTL3MBTL1KMT2AMEN1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8735622-B2 Histone demethylase inhibitors and methods for using the same THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) 2014-05-27 US disclosed
US-8735622-B2 Histone demethylase inhibitors and methods for using the same THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) 2014-05-27 US disclosed
US-20130137720-A1 HISTONE DEMETHYLASE INHIBITORS AND METHODS FOR USING THE SAME The Regents of the University of Colorado, a body corporated (US) 2013-05-30 US disclosed
US-20130137720-A1 HISTONE DEMETHYLASE INHIBITORS AND METHODS FOR USING THE SAME The Regents of the University of Colorado, a body corporated (US) 2013-05-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130137720-A1 HISTONE DEMETHYLASE INHIBITORS AND METHODS FOR USING THE SAME KDM1A, KDM3A, KDM7A NAMPT 1435/4885LSS 1085/4885L3MBTL1 104/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.